Bayesian decision sequential analysis with survival endpoint in phase II clinical trials

Statistics in Medicine

Volumn 28, Issue 9, 2009, Pages 1339-1352

  Zhao, Lili ^a   Woodworth, George ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Bayesian sequential; Clinical trials; Decision theory; Interim analysis; Time to event

Indexed keywords

ARTICLE; BAYES THEOREM; CLINICAL STUDY; DATA ANALYSIS; EXPERIMENTAL DESIGN; LINEAR SYSTEM; MATHEMATICAL ANALYSIS; MATHEMATICAL COMPUTING; POWER OF A TEST; RECEIVER OPERATING CHARACTERISTIC; SEQUENTIAL ANALYSIS; STATISTICAL DISTRIBUTION; STATISTICAL SIGNIFICANCE; SURVIVAL; SYSTEMATIC ERROR; BIOASSAY; BIOMETRY; DECISION THEORY; HUMAN; PATIENT; PHASE 2 CLINICAL TRIAL; SAMPLE SIZE; STATISTICAL MODEL; STATISTICS; TIME;

BAYES THEOREM; BIOMETRY; CLINICAL TRIALS, PHASE II AS TOPIC; DECISION THEORY; ENDPOINT DETERMINATION; HUMANS; MODELS, STATISTICAL; PATIENT DROPOUTS; SAMPLE SIZE; TIME FACTORS;

EID: 67549151410     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.3544     Document Type: Article

References (12)

1. Cheung YK, Thall PF. Monitoring the rates of composite events with censored data in phase II clinical trials. Biometrika 2002; 58:89-97.
2. Follmann DA, Albert PS. Bayesian monitoring of event rates with censored data. Biometrics 1999; 55:603-607.
3. Rosner GL. Bayesian monitoring of clinical trials with failure-time endpoints. Biometrics 2005; 61:239-245.
4. Thall PF, Wooten LH, Tannir NM. Monitoring event times in early phase clinical trials: some practical issues. Clinical Trials 2005; 2:467-478. DOI: 10.1191/1740774505cn121oa.
5. Berger JO. Statistical Decision Theory and Bayesian Analysis. Springer: New York, 1985.
6. DeGroot MR. Optimal Statistical Decisions. McGraw-Hill: New York, 1970.
7. Carlin BP, Kadane JB, Gelfand AE. Approaches for optimal sequential decision analysis in clinical trials. Biometrics 1998; 54:964-975.
8. Brockwell AE, Kadane JB. A gridding method for Bayesian sequential decision problems. Journal of Computational and Graphical Statistics 2003; 12:566-584.
9. O'Malley AJ. Applied Bayesian Statistical Studies in Biology and Medicine. Springer: New York, 2004.
10. Leung DH, Wang YG. A Bayesian decision approach for sample size determination in phase II trials. Biometrics 2001; 57:309-312.
11. Pham-Gia T, Turkkan N. Sample size determination in Bayesian analysis. The Statistician 1992; 41:389-397.
12. Stallard N. Sample size determination for phase II clinical trials based on Bayesian decision theory. Biometrics 1998; 54:279-294.